Through our Data Artistry program we strive to build capabilities in MEL, data analysis, reporting, visualisation and communication among development professionals.
ImpactBoard is a data management system that provides programmes with intelligence to achieve impact.
Ayanda is a social entrepreneur, strategist, and McKinsey trained management consultant with over 9 years’ experience working in the private and public sectors. He has previously held the position of Head of Advisory Services at New Leaders Foundation and now heads the Data Innovators entity as CEO.
In his commitment to transforming the South African Education system, Ayanda developed a dashboard solution on the state of Early Childhood Development readiness in the context of the COVID-19 pandemic to inform decisions and support. Currently, Ayanda also holds the position of Treasurer for the South African Monitoring Evaluation Association (SAMEA).
Jerusha is an entrepreneur, data creative, and Monitoring and Evaluation specialist. She has worked extensively in promoting the use of information for decision making and experiential sharing in the African public sector and across the globe.
Jerusha has previously been featured as an entrepreneur in publications such as, Insight Success, Entrepreneur Magazine SA, Destiny, and Destiny Man Magazines. She is passionate about telling stories with data, and teaching others to do so and is a legacy board member of the South African Monitoring and Evaluation Association.
Mary-Grace is a strategist and Technical Director for the Strategy and Business Development unit at Data Innovators. In her career that spans over 20 years, she has developed functional expertise in research, monitoring and evaluation, and policy development and implementation. She has also managed various projects involving key education sector stakeholders within the South African and international public sector.
In 2010, Mary-Grace was awarded the Institute of Education Sciences Post-Doctoral Research Fellowship in Science Education where she was instrumental in leading a randomised controlled trial in the United States of America.